FDA Import Refusal 799-6435227-2/11/1 — Apotex Inc.

Apotex Inc. — FEI 3002906944

The FDA refused shipment 799-6435227-2/11/1 from Apotex Inc. (Canada) on Aug 8, 2023. The refused product falls under Drugs and Biologics — METHOTREXATE SODIUM (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Aug 8, 2023
Country
Canada
Product Category
Drugs and Biologics
Product Code
62ICA32 METHOTREXATE SODIUM (ANTI-NEOPLASTIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.